CEO Kenvue Thibaut Monson on the New York Stock Exchange for the starting public offer, May 4, 2023.
Source: Nyse
Kenvue They set their proxy struggle with the activist value of the right part, the sources say CNBC David Faber.
Jeff Smith on the Falssorboard will join the Johnson & Johnson Spinoff committee, along with two new independent directors not associated with the activist, sources said.
Kenvue is a manufacturer of iconic brands known to investors and wider public, such as Aveeno, Band-Aid, Listerine, Neutrogen, Tylenol and J & J names and nameski children’s powder and shampoo. J&J ended his separation from Kenvue in August 2023, but the pharmaceutical company still has a share of a wide consumption giant.
Sources told CNBC yes in October collected a significant stake at the company and expressed disappointment for its management and stake in prices.
This is news. Refresh for updates.
